glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma The Vital Role of Highly
The Vital Role of Highly Characterized Glioblastoma PDX Models in Preclinical Cancer Research: Insights from TD2's Frontiers Clinically relevant glioblastoma patient derived xenograft models to guide drug development and identify molecular signatures CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia induced invasion, and therapeutic resistance bioRxiv Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Frontiers Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




